Literature DB >> 15811769

Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis.

Shinji Togo1, Kuniya Tanaka, Daisuke Morioka, Mitsutaka Sugita, Michio Ueda, Yasuhiko Miura, Toru Kubota, Yasuhiko Nagano, Kenichi Matsuo, Itaru Endo, Hitoshi Sekido, Hiroshi Shimada.   

Abstract

OBJECTIVE: Nutritional disturbances such as ascites and hypoalbuminemia frequently arise after hepatectomy for liver cancer with liver cirrhosis. We examined the possibility of maintaining a favorable state of nutrition by outpatient administration of branched-chain amino acid (BCAA) granules.
METHODS: Forty-three patients who had gross liver cirrhosis complicated by liver cancer and underwent surgery up to May 2002 were given BCAA granules (n = 21, BCAA group) or no granules (n = 22, control group).
RESULTS: 1) Background details such as age, sex, surgical technique, blood loss, and duration of surgery showed no significant differences. 2) Among objective findings, improvement of ascites and edema tended to occur sooner in the BCAA group, but without a significant difference. 3) Although serum albumin recovered its preoperative value 9 mo after surgery in the control group, only 6 mo was required for recovery in the BCAA group. Total protein showed similar changes, but neither group showed any difference in changes of aspartate aminotransferase, alanine transferase, or platelets. 4) One year postoperatively, the change from the preoperative indocyanine green retention rate at 15 min after intravenous administration tended to be worse in the control group, but not significantly so. 5) In the BCAA group, hyaluronic acid and type IV collagen 7S improved significantly sooner than in the control group.
CONCLUSIONS: BCAA supplementation after hepatectomy promotes rapid improvement in protein metabolism and inhibits progression to liver cirrhosis. Administration of BCAA after hepatectomy is considered beneficial to a patient's nutritional state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811769     DOI: 10.1016/j.nut.2004.07.017

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  17 in total

Review 1.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

Review 2.  Nutritional support for liver disease.

Authors:  Ronald L Koretz; Alison Avenell; Timothy O Lipman
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Tokio Higaki; Masamichi Moriguchi; Nao Yoshida; Teruyuki Miyazaki; Yoichi Teshima
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

Review 4.  Perioperative nutritional support and fluid therapy in patients with liver diseases.

Authors:  Yongliang Sun; Zhiying Yang; Haidong Tan
Journal:  Hepatobiliary Surg Nutr       Date:  2014-06       Impact factor: 7.293

5.  Anti-inflammatory and anti-genotoxic activity of branched chain amino acids (BCAA) in lipopolysaccharide (LPS) stimulated RAW 264.7 macrophages.

Authors:  Jae Hoon Lee; Eunju Park; Hyue Ju Jin; Yunjeong Lee; Seung Jun Choi; Gyu Whan Lee; Pahn-Shick Chang; Hyun-Dong Paik
Journal:  Food Sci Biotechnol       Date:  2017-08-18       Impact factor: 2.391

6.  Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study.

Authors:  Kengo Ichikawa; Takehiro Okabayashi; Hiromichi Maeda; Tsutomu Namikawa; Tatsuo Iiyama; Takeki Sugimoto; Michiya Kobayashi; Toshiki Mimura; Kazuhiro Hanazaki
Journal:  Surg Today       Date:  2012-08-14       Impact factor: 2.549

Review 7.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 8.  Branched-chain amino acids in liver diseases.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-30

Review 9.  Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function.

Authors:  Taro Takami; Takahiro Yamasaki; Issei Saeki; Toshihiko Matsumoto; Yutaka Suehiro; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

10.  Patient preparation before surgery for cholangiocarcinoma.

Authors:  E Oussoultzoglou; D Jaeck
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.